stars 1 stars 2 stars 3

DeuteRx has pioneered DECS (deuterium-enabled chiral switching) to create differentiated new chemical entities (NCEs) with new composition of matter patent protection and the potential for an expedited and derisked development path. Our success includes 4 M&A transactions, a Phase 2b NASH drug candidate (PXL065 in collaboration with Poxel SA), surprising discoveries with molecular glue degraders, and >50 issued patents.

DeuteRx Questions

The DeuteRx annual revenue was $1 million in 2026.

Sheila Dewitt is the Chair, President, CEO and Founder of DeuteRx.

3 people are employed at DeuteRx.

DeuteRx is based in Bedford, New Hampshire.

The NAICS codes for DeuteRx are [325, 32541, 32, 3254].

The SIC codes for DeuteRx are [28, 283].

Top DeuteRx Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users